We recently compiled a list of the 11 AI News You Should Not Miss. In this article, we are going to take a look at where ...

Fintel reports that on December 11, 2024, Roth MKM initiated coverage of Bloom Energy (NYSE:BE) with a Neutral recommendation ...

Analysts at Roth Capital issued their Q1 2026 EPS estimates for shares of Uranium Energy in a research report issued to clients and investors on Monday, December 9th. Roth Capital analyst J. Reagor ...

Yext (NYSE:YEXT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday,Benzinga reports. They presently have a $10.50 target ...

Roth MKM analyst Mike Niehuser maintained a Buy rating on Solitario Exploration & Royalty (XPL – Research Report) yesterday and set a price ...

Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 from $45 and keeps a Buy rating on the shares. The company has reported ...

Roth MKM last night initiated coverage of Entrada Therapeutics (TRDA) with a Buy rating and $29 price target Entrada is an ...

Roth MKM last night initiated coverage of Longeveron (LGVN) with a Buy rating and $10 price target The firm says its ...

Shares of Inseego (NASDAQ:INSG) moved higher in premarket trading on Thursday as Roth MKM raised its rating on the SaaS solutions provider to Buy and raised its price target on the stock to $15 ...

As of December 3, 2024, the average one-year price target for Longeveron is $8.67/share. The forecasts range from a low of $6.06 to a high of $10.50. The average price target represents an ...

As of December 3, 2024, the average one-year price target for CervoMed is $54.74/share. The forecasts range from a low of $34.34 to a high of $73.50. The average price target represents an ...

On Thursday, Roth/MKM downgraded MAG Silver (NYSE:MAG) stock from Buy to Neutral, adjusting the price target slightly higher to $17.50, up from the previous $17.00. The revision follows the company's ...